Medicaid expansion removes age caps, expands home care, tightens payment accuracy

What it does

This bill extends and modifies Medicaid and CHIP health care provisions. It streamlines enrollment for out-of-state providers, expands home and community-based services (HCBS) with new transparency requirements and a demonstration program, removes age caps on Medicaid eligibility for working adults with disabilities, ensures military families maintain Medicaid coverage during relocation, improves address verification to prevent payments to deceased beneficiaries, delays juvenile justice screening requirements, mandates state studies on maternity care costs, adjusts disproportionate share hospital (DSH) payments, and overhauls pharmacy price survey methodology to ensure accurate reimbursement.

Why we flagged it

The bill's core function is to expand Medicaid/CHIP eligibility and access (removing age restrictions, adding military family protections, expanding HCBS), while simultaneously imposing new transparency and verification requirements on states and providers. It is fundamentally a public-benefit expansion with administrative oversight provisions.

What the text implies

• Pharmacy survey penalties (up to $100,000 per violation) may increase compliance costs for small and rural pharmacies, potentially affecting drug availability in underserved areas if pharmacies exit the market.
• Demonstration program for HCBS expansion is limited to 5 states; geographic diversity preference may leave many states without access to expanded services, creating unequal access across the country.
• Quarterly Death Master File checks and address verification requirements impose significant administrative burden on states; implementation delays or errors could temporarily disenroll eligible beneficiaries.
• Military family provisions (effective Jan 1, 2028) preserve HCBS waiting list position but do not guarantee service availability; families may remain on waiting lists indefinitely in states with capacity limits.
• Maternity care cost studies are mandated but non-binding; no mechanism ensures states or CMS will use findings to adjust payment rates, limiting practical impact on hospital viability.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens gain expanded Medicaid eligibility (removal of age caps for disabled workers, military family protections), improved access to home and community-based services, stronger safeguards against erroneous payments to deceased individuals, and more transparent state reporting on service availability and costs. The bill imposes compliance costs on states and providers but does not restrict citizen rights or remedies.

Who stands to gain

• home and community-based service providers
• out-of-state healthcare providers (via streamlined enrollment)
• hospitals providing maternity services (via cost study and DSH adjustments)
• pharmacy benefit managers and survey vendors (via pharmacy pricing oversight contracts)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS), State Medicaid agencies, State CHIP programs, Medicaid managed care entities, Retail community pharmacies, Non-retail pharmacies, Disproportionate share hospitals (DSH), Armed Forces, Death Master File, Pharmacy benefit managers

Where it stands

1 cosponsor: 1 Independents.

• Mar 6, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Mar 6, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

33 lobbying clients named this bill on 44 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $16,073,170 in lobbying spend. A filing names 6 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 98% of bills with at least one filing.

Ron Wyden, the sponsor, reported $375,070 in PAC receipts in the 2026 cycle. $2,500 of that came from 1 PAC tied to these lobbying clients.

• Pharmaceutical Research and Manufacturers of America — $8,410,000 on 1 filing
• American Academy of Family Physicians — $1,715,904 on 2 filings
• Cambia Health Solutions — $1,330,000 on 2 filings
• Eisai Inc. — $710,000 on 1 filing
• Emd Serono Inc — $700,000 on 1 filing

Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.